A brief history of lipid and lipoprotein measurements and their contribution to clinical chemistry

Clinica Chimica Acta

Volumn 369, Issue 2, 2006, Pages 158-167

  McNamara, Judith R ^a   Warnick, G Russell ^b   Cooper, Gerald R ^c  

^a TUFTS UNIVERSITY   (United States)

^b Berkeley HeartLab Inc   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Cholesterol; Lipid; Lipoproteins; Metabolism

Indexed keywords

CHOLESTEROL; GLYCEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REAGENT; TRIACYLGLYCEROL;

ACCURACY; AGAR GEL ELECTROPHORESIS; ATHEROSCLEROSIS; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL CHEMISTRY; COLORIMETRY; CORRELATION ANALYSIS; ELECTROIMMUNOASSAY; EXPERIMENTAL ANIMAL; FATTY ACID ANALYSIS; GEL CHROMATOGRAPHY; HISTORY; HUMAN; IMMUNOASSAY; IMMUNODIFFUSION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAPER ELECTROPHORESIS; PATHOPHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; RABBIT; RADIOIMMUNOASSAY; REVIEW; SEPARATION TECHNIQUE; STANDARD; STANDARDIZATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ULTRACENTRIFUGATION; VASCULAR DISEASE;

CHEMISTRY, CLINICAL; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LIPIDS; LIPOPROTEINS;

GLYCERINE;

EID: 33746904797     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.041     Document Type: Review

References (147)

1. Olson R.E. Discovery of the lipoproteins, their role in fat transport and their significance as risk factors. J Nutr 128 (1998) 439S-443S
2. Dam H. Historical introduction to cholesterol. In: Cook R.P. (Ed). Chemistry, Biochemistry and Pathology (1938), Academic Press, New York 1-14
3. De Fourcroy A.F. De la substance feuilletee et crystalline contenue dans les calculs biliaries et de la nature des concretions cystiques cristalisees. Ann Chim 3 (1789) 242-252
4. Leray C., http://www.cyberlipid.org/chevreul/chevreul.htm.
5. Chevreul M.E. Recherches chimiques sur plusieurs corps gras, et particulièrement sur leurs combinaisons avec les alcalis. Mémoire 1 - Sur une substance nouvelle obtenue du savon de graisse et de potasse. Ann Chim 88 (1813) 225-261
6. Chevreul M.E. Examen chimique du savon des graisses de porc et de potasse. Ann Chim 94 (1815) 80-107
7. Chevreul M.E. De la saponification de la graisse de porc, et de sa composition. Ann Chim 94 (1815) 113-144
8. Chevreul M.E. De l'action de quelques bases salifiables sur la graisse de porc, et des capacités de saturation de la margarine et de la graisse fluide. Ann Chim 94 (1815) 225-280
9. Rayer, PFO. Traité théorique et pratique des maladies de la peau. 2 volumes and atlas. Paris, Baillière, 1826-1827. 2nd edition, in 3 volumes with atlas, Paris Baillière, 1835. English tanslation, 1883.
10. Virchow R. Gesammelte Abhandlungen zur Wissenschaftlichen Medicin (1856), Medinger Sohn, Frankfurt-am-Main 499-513
11. Berthelot M. Sur plusiers alcools nouveaux. Ann Chim Phys 56 (1859) 51-98
12. Hood B. Alexander Borodin: multi-talented chemical pathologist. Bull R Coll Pathol 126 (2004) 31-32
13. Salkowski F. Die reaction des cholesterin mit schwefelsaure. Arch Dtsch Ges Physiol 6 (1872) 207
14. Liebermann C. Ueber des oxychinoterpen. Ber Dtsch Chem Ges 18 (1885) 1803
15. Burchard H. Beitrage zur kenntnis des cholesterins. Chem Zentralbl 610 (1890)
16. Abell L.L., Levy B.B., Brodie B.B., and Kendall F.E. A simplified method for the estimation of blood cholesterol in serum and demonstration of its specificity. J Biol Chem 195 (1952) 357-366
17. Duncan I.W., Mather A., and Cooper G.R. The procedure for the proposed cholesterol reference method (1988), Centers for Disease Control, Atlanta, GA
18. Cooper G.R., Smith S.J., Duncan I.W., et al. Interlaboratory testing of the transferability of a candidate reference method for total cholesterol in serum. Clin Chem 32 (1986) 921-929
19. Frederickson D.S. Phenotyping: on reaching base camp (1950-1975). Circulation 87 Supp III (1993) III-1-III-15
20. Windaus A. Uber die quantitative bestimmung des cholesterine und der cholesterinester in einigen normalen und pathologischen nieren. Z Physiol Chem 65 (1910) 110
21. Grigaut A. Procede colorimetrique de dosage de la cholesterine dans l'organisme. C R Soc Biol 68 (1910) 791
22. Meites S. Otto Folin: America's first clinical biochemist (1989), AACC Press, Washington, DC 206
23. Zak B. Cholesterol methodologies: a review. Clin Chem 23 (1977) 1201-1214
24. Mehta N.J., and Khan I.A. Cardiology's 10 greatest discoveries of the 20th century. Texas Heart Inst J 29 (2002) 164-171
25. Mutt V. In: Frangsmyr T., and Lindsten J. (Eds). Nobel lectures, physiology or medicine 1981-1990 (1993), World Scientific Pub Co, Singapore
26. Goldstein J.L., and Brown M.S. Cholesterol: a century of research. Howard Hughes Med Inst Bull 16 (2003)
27. Pickels E.G. The ultracentrifuge: practical aspects of the ultracentrifugal analysis of proteins. Chem Rev 30 (1942) 341-355
28. McFarlane A.S. LXXIX: The ultracentrifugal protein sedimentation diagram of normal human, cow, and horse serum. Biochem J 29 (1935) 660-693
29. Pedersen K.O. On a low-density lipoprotein appearing in normal human plasma. J Phys Chem 51 (1947) 156-163
30. Gofman J.W., Lindgren F.T., and Elliott H. Ultracentrifugal studies of lipoproteins of human serum. J Biol Chem 179 (1949) 973-979
31. Lindgren F.T., Elliott H.A., and Gofman J.W. The ultracentrifugal characterization and isolation of human blood lipids and lipoproteins, with applications to the study of atherosclerosis. J Phys Chem 55 (1951) 80-93
32. Vartiainen I., and Kanerva K. Arteriosclerosis and war-time. Ann Med Intern Fenn 36 (1947) 748
33. Schoenheimer R., and Sperry W.M. A micromethod for the determination of serum cholesterol. J Biol Chem 106 (1934) 745-760
34. Cooper GR. A short history of the Lipid Standardization Program: how the CDC-NHLBI Lipid Standardization Program (LSP) was established. Fats of Life, 16(3), 2002, 1,6-8,11-3.
35. Flegg H.M. An investigation of the determination of serum cholesterol by an enzymatic method. Ann Clin Biochem 10 (1973) 79-84
36. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19 (1973) 1350-1356
37. McNamara J.R., and Schaefer E.J. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 166 (1987) 1-8
38. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
39. Siedel J., Hagele E.O., Ziegenhorn J., and Wahlefeld A.W. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29 (1983) 1075-1080
40. Wiebe D.A., and Bernert Jr. J.T. Influence of incomplete cholesterol ester hydrolysis on enzymic measurement of cholesterol. Clin Chem 30 (1984) 352-356
41. Klotzsch S.G., and McNamara J.R. Triglyceride measurements: a review of methods and interferences. Clin Chem 36 (1990) 1605-1613
42. Van Handel E., and Zilversmit D.B. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med 50 (1957) 152-157
43. Carlson L.A., and Wadström L.B. Determination of serum glycerides in blood serum. Clin Chim Acta 4 (1959) 197-205
44. Cooper G.R., Myers G.L., and Henderson L.O. Establishment of reference methods for lipids, lipoproteins, and apolipoproteins. Eur J Clin Chem Clin Biochem 29 (1991) 269-275
45. Wieland O. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis. 1st ed. (1965), Academic Press, New York 211-214
46. Kessler G., and Lederer H. Fluorimetric measurements of triglycerides. In: Skeggs Jr. L.T. (Ed). Automation in analytical chemistry (1966), Mediad, New York 341-344
47. Bucolo G., and David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 19 (1974) 475-482
48. Burstein M., and Samaille J. Sur la precipitation selective des B lipoproteines du serum par l'heparine et les heparinoides de synthese en presence du Cl2Ca. J Physiol 49 (1957) 83-86
49. Nauck M., Wiebe D., and Warnick G.R. Measurement of high-density-lipoprotein cholesterol. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 2nd edition (2000), AACC Press, Washington, DC 221-244
50. Warnick G.R., Benderson J., and Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
51. Wiebe D.A., and Smith S.J. Six methods for isolating high-density lipoprotein compared with use of the reference method for quantifying cholesterol in serum. Clin Chem 31 (1985) 746-750
52. Havel R.J., Eder H.A., and Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34 (1955) 1345-1353
53. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
54. Bachorik P.S., Ross J.W., and for the National Cholesterol Education Program Working Group on Lipoprotein Measurement. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. Clin Chem 41 (1995) 1414-1420
55. Wieland H., and Seidel D. A simple method for precipitation of low density lipoproteins. J Lipid Res 24 (1983) 904-909
56. McNamara J.R., Cole T.G., Contois J.H., Ferguson C.A., Ordovas J.M., and Schaefer E.J. Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated. Clin Chem 41 (1995) 232-240
57. Pisani T., Gepsky C.P., Leary E.T., Warnick G.R., and Ollington J.F. Accurate direct determination of low-density lipoprotein cholesterol using an immunoseparation reagent and enzymatic cholesterol assay. Arch Pathol Lab Med 119 (1995) 1127-1135
58. Sugiuchi H., Irie T., Uji Y., et al. Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and α-cyclodextrin sulfate. Clin Chem 44 (1998) 522-531
59. 2+ method. Clin Chem 44 (1998) 1242-1250
60. Sugiuchi H., Uji Y., Okabe H., et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clin Chem 41 (1995) 717-723
61. Warnick G.R., Nauck M., and Rifai N. Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem 47 (2001) 1579-1596
62. Nauck M., Warnick G.R., and Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48 (2002) 236-254
63. Cohen A., Hertz H.S., Mandel J., et al. Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. Clin Chem 26 (1980) 854-860
64. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 20 251 (1984) 351-364
65. Laboratory Methods Committee of the Lipid Research Clinics Program. Cholesterol and triglyceride concentrations in serum/plasma pairs. Clin Chem 23 (1977) 60-63
66. Lipid Research Clinics Program. Manual of Laboratory Operations, Vol 1, Lipid and lipoprotein analysis, 2nd ed. Pub. No. 75-628. National Heart and Lung Institute, National Institutes of Health, Bethesda, MD, 1982.
67. Special report. Lowering blood cholesterol to prevent heart disease: NIH Consensus Development Conference statement. Arteriosclerosis 5 (1985) 404-412
68. Expert panel. Report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 148 (1988) 36-69
69. Special report. Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Clin Chem 34 (1988) 193-201
70. Tan M.H., Wilmshurst E.G., Gleason R.E., and Soeldner J.S. Effect of posture on serum lipids. N Engl J Med 289 (1973) 416-419
71. Demacker P.N., Schade R.W., Jansen R.T., and Van 't Laar A. Intra-individual variation of serum cholesterol, triglycerides and high density lipoprotein cholesterol in normal humans. Atherosclerosis 45 (1982) 259-266
72. Costongs G.M., Janson P.C., Bas B.M., Hermans J., van Wersch J.W., and Brombacher P.J. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 23 (1985) 7-16
73. Cooper G.R., Smith S.J., Myers G.L., Sampson E.J., and Magid E. Estimating and minimizing effects of biologic sources of variation by relative range when measuring the mean of serum lipids and lipoproteins. Clin Chem 40 (1994) 227-232
74. Cooper GR. The Lipids and Lipoproteins Division: a retrospective. Fats of Life 1998;12(3):1,9-11.
75. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 2nd edition (2000), AACC Press, Washington, DC 819 pp.
76. Aladjem F., Lieberman M., and Gofman J.W. Immunochemical studies on human plasma lipoproteins. J Exp Med 105 (1957) 49-67
77. deLalla L., Levine L., Ray K., and Brown R.K. Immunologic studies of human high density lipoproteins. J Exp Med 106 (1957) 261-271
78. Scanu A., Lewis L.A., and Bumpus F.M. Separation and characterization of the protein moiety of human α1-lipoprotein. Arch Biochem Biophys 74 (1958) 390-397
79. Alaupovic P. Apolipoproteins and lipoproteins. Atherosclerosis 13 (1971) 141-146
80. Curry M.D., Gustafson A., Alaupovic P., and McConathy W.J. Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem 24 (1978) 280-286
81. Durrington P.N., Bolton C.H., and Hartog M. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia. Clin Chim Acta 82 (1978) 151-160
82. Albers J.J., Wahl P.W., Cabana V.G., Hazzard W.R., and Hoover J.J. Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism 25 (1976) 633-644
83. Brewer Jr. H.B., Gregg R.E., Hoeg J.M., and Fojo S.S. Apolipoproteins and lipoproteins in human plasma: an overview. Clin Chem 34 (1988) B4-B8
84. Alaupovic P., McConathy W.J., Fesmire J., Tavella M., and Bard J.M. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. Clin Chem 34 (1988) B13-B27
85. Cooper G.R., Smith S.J., Wiebe D.A., Kuchmak M., and Hannon W.H. International survey by apolipoproteins A-I and B measurements (1983-84). Clin Chem 31 (1985) 223-228
86. Marcovina S.M., Albers J.J., Dati F., Ledue T.B., and Ritchie R.F. International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. Clin Chem 37 (1991) 1676-1682
87. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 59 (1963) 362-382
88. Albers J.J., Kennedy H., and Marcovina S.M. Evidence that Lp(a) contains one molecule of apo(a) and one molecule of apo B: evaluation of amino acid analysis data. J Lipid Res 37 (1996) 192-196
89. McLean J.W., Tomlinson J.E., Kuang W.-J., et al. Nature 330 (1987) 132-137
90. Marcovina S.M., Albers J.J., Gabel B., Koschinsky M.L., and Gaur V.P. Effect of the number of aoplipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 41 (1995) 246-255
91. Marcovina S.M., and Koschinsky M.L. Lipoprotein(a): structure, measurement, and clinical significance. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 2nd edition (2000), AACC Press, Washington, DC 345-385
92. Seman L.J., Jenner J.L., McNamara J.R., and Schaefer E.J. Quantitation of plasma lipoprotein (a) by cholesterol assay of lectin-bound lipoprotein (a). Clin Chem 40 (1994) 400-403
93. Tate J.R., Berg K., Couderc R., et al. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) standardization project for the measurement of lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a). Clin Chem Lab Med 37 (1999) 949-958
94. Dati F., Tate J.R., Marcovina S.M., and Steinmetz A. International Federation of Clinical Chemistry and Laboratory Medicine; IFCC Working Group for Lipoprotein(a) Assay Standardization. First WHO/IFCC international reference reagent for lipoprotein(a) for immunoassay-Lp(a) SRM 2B. Clin Chem Lab Med 42 (2004) 670-676
95. Bennhold H. Ueber die vehikelfunction der serumeiweiskorper. Ergebn Inn Med Kinderheilkd 42 (1932) 273-375
96. Blix G., Tiselius A., and Svensson H. Lipids and polysaccharides in electrophoretically separated blood serum proteins. J Biol Chem 137 (1941) 485-494
97. Cooper G.R., and Mandel E.E. Paper electrophoresis with automatic scanning and recording. J Lab Clin Med 44 (1954) 636-643
98. Fredrickson D.S., and Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 31 (1965) 321-327
99. Lees R.S., and Hatch F.T. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med 61 (1963) 518-528
100. Papadopoulos N.M. Abnormal lipoprotein patterns in human serum as determined by agarose gel electrophoresis. Clin Chem 25 (1979) 1885-1887
101. Grundy S.M. Richard Havel, Howard Eder, and the evolution of lipoprotein analysis. J Clin Invest 114 (2004) 1034-1037
102. Lindgren F.T., Nichols A.V., Freeman N.K., Wills R.D., Wing L., and Gullberg J.E. Analysis of low-density lipoproteins by preparative ultracentrifugation and refractometry. J Lipid Res 15 (1964) 68-74
103. Nichols A.V. Human serum lipoproteins and their interrelationships. Adv Biol Med Phys 11 (1967) 109-158
104. Williams J.W. The development of the ultracentrifuge and its contributions. Ann N Y Acad Sci 325 (1979) 76-92
105. Caslake M.J., and Packard C.J. The use of ultracentrifugation for the separation of lipoproteins. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 2nd edition (2000), AACC Press, Washington, DC 625-669
106. deLalla O.F., Elliott H.A., and Gofman J.W. Ultracentrifugal studies of high-density serum lipoproteins in clinically healthy adults. Am J Physiol 179 (1954) 333-337
107. Chung B.H., Wilkinson T., Geer J.C., and Segrest J.P. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 21 (1980) 284-291
108. Chapman M.J., Goldstein S., Lagrange D., and Laplaud P.M. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 22 (1981) 339-358
109. Griffin B.A., Caslake M.J., Yip B., Tait G.W., Packard C.J., and Shepherd J. Rapid isolation of low-density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 83 (1990) 59-67
110. Graham J.M., Higgins J.A., Gillott T., et al. A novel method for the rapid separation of plasma lipoproteins using self-generating gradients of iodixanol. Atherosclerosis 124 (1996) 125-135
111. Krauss R.M., and Burke D.J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23 (1982) 97-104
112. Muniz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin Chem 23 (1977) 1826-1833
113. McNamara J.R., Campos H., Ordovas J.M., Peterson J., Wilson P.W.F., and Schaefer E.J. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution: Results from the Framingham Offspring Study. Arteriosclerosis 7 (1987) 483-490
114. McNamara J.R., Small D.M., Li Z., and Schaefer E.J. Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B. J Lipid Res 37 (1996) 1924-1935
115. Li Z., McNamara J.R., Ordovas J.M., and Schaefer E.J. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid Res 35 (1994) 1698-1711
116. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., and Krauss R.M. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260 (1988) 1917-1921
117. Campos H., Genest J.J., Blijlevens E., et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 12 (1992) 187-195
118. Steim J.M., Edner O.J., and Bargoot F.G. Structure of human serum lipoproteins: nuclear magnetic resonance supports a micellar model. Science 162 (1968) 909-911
119. Chapman D., Leslie R.B., Hirz R., and Scanu A.M. 220 MHz nuclear magnetic resonance spectra of high density serum lipoproteins. Nature 221 (1969) 260-261
120. Otvos J.D., Jeyarajah E.J., and Bennett D.W. Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 37 (1991) 377-386
121. Freedman D.S., Otvos J.D., Jeyarajah E.J., Barboriak J.J., Anderson A.J., and Walker J.A. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18 (1998) 1046-1053
122. Sata T., Havel R.J., and Jones A.L. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 13 (1972) 757-768
123. Okazaki M., and Hara I. Analysis of cholesterol in high density lipoprotein subfractions by high performance liquid chromatography. J Biochem (Tokyo) 88 (1980) 1215-1218
124. Okazaki M., Usui S., and Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 2nd edition (2000), AACC Press, Washington, DC 647-669
125. Zilversmit D.B. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 33 (1973) 633-638
126. Tatami R., Mabuchi H., Ueda K., et al. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64 (1981) 1174-1184
127. Havel R.J. The role of the liver in atherosclerosis. Arteriosclerosis 5 (1985) 569-580
128. Phillips N.R., Waters D., and Havel R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88 (1993) 2762-2770
129. Zilversmit D.B. Atherogenic nature of triglycerides, postprandial lipemia, and triglyceride-rich remnant lipoproteins. Clin Chem 41 (1995) 153-158
130. Davignon J., and Cohn J.S. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis 124 (1996) S57-S64 [Suppl]
131. Havel R.J. Triglyceride-rich lipoproteins. In: Rifai N., Warnick G.R., and Dominiczak M.H. (Eds). Handbook of lipoprotein testing. 3rd edition (1997), AACC Press, Washington, DC 115-126
132. Campos E., Nakajima K., Tanaka A., and Havel R.J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33 (1992) 369-380
133. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223 (1993) 53-71
134. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant lipoprotein cholesterol and triglyceride: reference ranges from the Framingham Heart Study. Clin Chem 44 (1998) 1224-1232
135. Leary E.T., Wang T., Baker D.J., et al. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin Chem 44 (1998) 2490-2498
136. Devaraj S., Vega G., Lange R., Grundy S.M., and Jailal I. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease. Am J Med 104 (1998) 445-450
137. Doi H., Kugiyama K., Ohgushi M., et al. Membrane active lipids in remnant lipoproteins cause impairment of endothelium-dependent vasorelaxation. Arterioscler Thromb Vasc Biol 19 (1999) 1918-1924
138. Nakamura T., Takano H., Umetani K., et al. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. Atherosclerosis 181 (2005) 321-327
139. Imke C., Rodriguez B.L., Grove J.S., et al. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study. Arterioscler Thromb Vasc Biol 25 (2005) 1718-1722
140. Stampfer M.J., Krauss R.M., Ma J., et al. A prospective study of triglyceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276 (1996) 882-888
141. St-Pierre A.C., Ruel I.L., Cantin B., et al. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation 104 (2001) 2295-2299
142. Barr D.P., Russ E.M., and Eder H.A. Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. Am J Med 11 (1951) 480-488
143. Enos W.F., Holmes R.H., and Beyer J. Coronary disease among United States soldiers killed in action in Korea: preliminary report. JAMA 152 (1953) 1090-1093
144. Gofman J.W., Hanig M., Jones H.B., et al. Evaluation of serum lipoproteins and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation 14 (1956) 691-725
145. Carlson L.A. Serum lipids in men with myocardial infarction. Acta Med Scand 167 (1960) 399-413
146. Goldstein J.L., Hazzard W.R., Schrott H.G., Bierman E.L., and Motulsky A.G. Hyperlipidemia in coronary heart disease I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 52 (1973) 1533-1543
147. Cooper G.R. History of selected lipoprotein research: 1950-2000. Fats of Life vol. 18(4) (2004) 9-19